Skip to main navigation Skip to search Skip to main content

Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria": Antimicrob Agents Chemother

C. Brunschwig, N. Lawrence, D. Taylor, E. Abay, M. Njoroge, G. S. Basarab, C. Le Manach, T. Paquet, D. Gonzalez Cabrera, A. T. Nchinda, C. de Kock, L. Wiesner, P. Denti, D. Waterson, B. Blasco, D. Leroy, M. J. Witty, C. Donini, J. Duffy, S. WittlinK. L. White, S. A. Charman, M. B. Jimenez-Diaz, I. Angulo-Barturen, E. Herreros, F. J. Gamo, R. Rochford, D. Mancama, T. L. Coetzer, M. E. van der Watt, J. Reader, L. M. Birkholtz, K. C. Marsh, S. M. Solapure, J. E. Burke, J. A. McPhail, M. Vanaerschot, D. A. Fidock, P. V. Fish, P. Siegl, D. A. Smith, G. Wirjanata, R. Noviyanti, R. N. Price, J. Marfurt, K. D. Silue, L. J. Street, K. Chibale

Research output: Contribution to journalComment/debate

Abstract

[No abstract available]
Original languageEnglish
Pages (from-to)1-2
Number of pages2
JournalAntimicrobial Agents and Chemotherapy
Volume62
Issue number11
DOIs
Publication statusPublished - 27 Nov 2018

Bibliographical note

Erratum for Brunschwig et al., “UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria”,
Volume 62, no. 9, e00012-18, 2018, https://doi.org/10.1128/AAC.00012-18. Page 7.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria": Antimicrob Agents Chemother'. Together they form a unique fingerprint.

Cite this